A Phase I/II Study of HLA-matched Mobilized Peripheral Blood Hematopoietic Stem Cell Transplantation for Advanced Mycosis Fungoides/Sezary Syndrome Using Nonmyeloablative Conditioning With Campath-1H
Latest Information Update: 25 Sep 2023
At a glance
- Drugs Alemtuzumab (Primary) ; Ciclosporin; Cyclophosphamide; Fludarabine; Mycophenolate mofetil
- Indications Mycosis fungoides; Sezary syndrome
- Focus Therapeutic Use
- 25 Jan 2019 Status changed from active, no longer recruiting to completed.
- 25 Jan 2019 Status changed from active, no longer recruiting to completed.
- 02 Mar 2018 Planned End Date changed from 30 Dec 2018 to 1 Jul 2021.